Marilyn A. Huestis

18.3k total citations · 3 hit papers
292 papers, 13.3k citations indexed

About

Marilyn A. Huestis is a scholar working on Toxicology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Marilyn A. Huestis has authored 292 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Toxicology, 151 papers in Pharmacology and 70 papers in Cellular and Molecular Neuroscience. Recurrent topics in Marilyn A. Huestis's work include Forensic Toxicology and Drug Analysis (174 papers), Cannabis and Cannabinoid Research (150 papers) and Neurotransmitter Receptor Influence on Behavior (62 papers). Marilyn A. Huestis is often cited by papers focused on Forensic Toxicology and Drug Analysis (174 papers), Cannabis and Cannabinoid Research (150 papers) and Neurotransmitter Receptor Influence on Behavior (62 papers). Marilyn A. Huestis collaborates with scholars based in United States, Italy and Canada. Marilyn A. Huestis's co-authors include Edward J. Cone, David A. Gorelick, Karl B. Scheidweiler, Allan J. Barnes, Marta Concheiro, Harrison G. Pope, Robert S. Goodwin, Eric T. Moolchan, Robin E. Choo and Amanda J. Gruber and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Marilyn A. Huestis

285 papers receiving 12.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Cannabinoid Pharmacokinetics

2007 833 citations Marilyn A. Huestis profile →
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

2011 424 citations Marilyn A. Huestis et al. Molecular Psychiatry profile →
Cannabidiol Adverse Effects and Toxicity

2019 290 citations Marilyn A. Huestis, Francesco Paolo Busardò et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marilyn A. Huestis United States	60	6.6k	5.2k	2.7k	2.1k	1.8k	292	13.3k
Marilyn A. Huestis United States	56	5.4k 0.8×	4.9k 0.9×	1.8k 0.7×	2.3k 1.1×	1.5k 0.8×	213	11.1k
Edward J. Cone United States	62	3.7k 0.6×	5.1k 1.0×	2.6k 1.0×	1.1k 0.5×	1.2k 0.6×	268	11.7k
Magı́ Farré Spain	56	3.5k 0.5×	4.1k 0.8×	3.2k 1.2×	626 0.3×	3.5k 1.9×	339	12.4k
Rafael de la Torre Spain	73	3.6k 0.5×	4.3k 0.8×	3.3k 1.2×	596 0.3×	3.7k 2.0×	475	20.1k
David A. Gorelick United States	52	4.3k 0.7×	2.4k 0.5×	2.8k 1.0×	509 0.2×	1.7k 0.9×	213	9.3k
Simona Pichini Italy	50	2.3k 0.3×	3.1k 0.6×	1.2k 0.4×	1.7k 0.8×	1.2k 0.7×	348	9.1k
Olaf H. Drummer Australia	54	2.3k 0.3×	4.3k 0.8×	865 0.3×	536 0.3×	993 0.5×	284	10.4k
George E. Bigelow United States	67	3.0k 0.5×	1.3k 0.2×	3.5k 1.3×	1.6k 0.8×	1.6k 0.8×	314	14.8k
Mauro Maccarrone Italy	82	14.2k 2.1×	1.2k 0.2×	6.5k 2.4×	1.8k 0.8×	511 0.3×	541	23.6k
Thomas R. Kosten United States	77	3.9k 0.6×	1.6k 0.3×	7.3k 2.7×	1.3k 0.6×	4.3k 2.3×	567	22.9k

Countries citing papers authored by Marilyn A. Huestis

Since Specialization

Citations

This map shows the geographic impact of Marilyn A. Huestis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn A. Huestis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn A. Huestis more than expected).

Fields of papers citing papers by Marilyn A. Huestis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn A. Huestis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn A. Huestis. The network helps show where Marilyn A. Huestis may publish in the future.

Co-authorship network of co-authors of Marilyn A. Huestis

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn A. Huestis. A scholar is included among the top collaborators of Marilyn A. Huestis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn A. Huestis. Marilyn A. Huestis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Herry, et al.. (2025). Cannabinoids in hair and their prospective association with mental and physical health outcomes in adolescents. Neurotoxicology and Teratology. 108. 107433–107433. 1 indexed citations

Wade, Natasha E., Alexander L. Wallace, Kelly E. Courtney, et al.. (2025). Cannabinoid profiling across toxicology samples in adolescents and young adults by route of administration and in relation to depression symptoms. Journal of Analytical Toxicology. 49(8). 567–575.

Mohr, Amanda L A, et al.. (2025). North America laboratory survey data for drug testing in drug-impaired driving and traffic fatality investigations. Journal of Analytical Toxicology. 49(7). 436–441. 1 indexed citations

Snozek, Christine L.H., Janetta Bryksin, Benjamin Gerson, et al.. (2024). Assessing knowledge gaps and educational needs in urine drug test interpretation among health care professionals. American Journal of Clinical Pathology. 163(1). 69–79. 1 indexed citations

Tagne, Alex Mabou, et al.. (2024). Comparative Pharmacokinetics of Δ9-Tetrahydrocannabinol in Adolescent and Adult Female Mice. Cannabis and Cannabinoid Research. 9(6). 1537–1542. 1 indexed citations

Klumpers, Linda E., et al.. (2024). Tolerability of High-Dose Oral Δ ⁹ -THC: Implications for Human Laboratory Study Design. Cannabis and Cannabinoid Research. 9(2). 437–448.

Antunes, Natalícia de Jesus, et al.. (2024). Metabolic Stability and Metabolite Identification of N-Ethyl Pentedrone Using Rat, Mouse and Human Liver Microsomes. Pharmaceutics. 16(2). 257–257. 10 indexed citations

Scherer, Juliana Nichterwitz, et al.. (2024). Reliability of roadside oral fluid testing devices for ∆⁹‐tetrahydrocannabinol (∆⁹‐THC) detection. Drug Testing and Analysis. 16(12). 1528–1536. 2 indexed citations

Huestis, Marilyn A., et al.. (2024). MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model‐informed analysis. CPT Pharmacometrics & Systems Pharmacology. 14(2). 376–388.

10.

Faro, Alfredo Fabrizio Lo, Tommaso Cassano, Gregory Dendramis, et al.. (2023). New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic. Biology. 12(2). 273–273. 20 indexed citations

11.

Marcotte, Thomas D., Anya Umlauf, David J. Grelotti, et al.. (2023). Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis. JAMA Psychiatry. 80(9). 914–914. 13 indexed citations

12.

Wade, Natasha E., Alexander L. Wallace, Marilyn A. Huestis, et al.. (2023). Cannabis use and neurocognitive performance at 13–14 Years-Old: Optimizing assessment with hair toxicology in the Adolescent brain cognitive development (ABCD) study. Addictive Behaviors. 150. 107930–107930. 5 indexed citations

13.

Ahmed, Faizy, et al.. (2022). A Sensitive Ultrahigh-Performance Liquid Chromatography/Tandem Mass Spectrometry Method for the Simultaneous Analysis of Phytocannabinoids and Endocannabinoids in Plasma and Brain. Cannabis and Cannabinoid Research. 9(1). 371–385. 9 indexed citations

14.

Ashley, David L., et al.. (2020). Urinary Acrylonitrile Metabolite Concentrations Before and after Smoked, Vaporized, and Oral Cannabis in Frequent and Occasional Cannabis Users. International Journal of Environmental Research and Public Health. 17(18). 6438–6438. 8 indexed citations

15.

Semick, Stephen A., Leonardo Collado‐Torres, Christina A. Markunas, et al.. (2018). Developmental effects of maternal smoking during pregnancy on the human frontal cortex transcriptome. Molecular Psychiatry. 25(12). 3267–3277. 16 indexed citations

16.

Shisler, Shannon, Rina D. Eiden, Danielle S. Molnar, et al.. (2017). Smoking in Pregnancy and Fetal Growth: The Case for More Intensive Assessment. Nicotine & Tobacco Research. 19(5). 525–531. 25 indexed citations

17.

Ellefsen, Kayla N., Marta Concheiro, Sandrine Pirard, David A. Gorelick, & Marilyn A. Huestis. (2016). Pharmacodynamic effects and relationships to plasma and oral fluid pharmacokinetics after intravenous cocaine administration. Drug and Alcohol Dependence. 163. 116–125. 15 indexed citations

18.

Abar, Beau, Linda L. LaGasse, Chris Derauf, et al.. (2012). Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition.. Psychology of Addictive Behaviors. 27(3). 662–673. 31 indexed citations

19.

Huestis, Marilyn A. & Michael L. Smith. (2006). Modern analytical technologies for the detection of drug abuse and doping. Drug Discovery Today Technologies. 3(1). 49–57. 18 indexed citations

20.

Cone, E. J., et al.. (2003). Urine Testing for Cocaine Abuse: Metabolic and Excretion Patterns following Different Routes of Administration and Methods for Detection of False-Negative Results. Journal of Analytical Toxicology. 27(7). 386–401. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact